http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100462431-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7158 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 |
| filingDate | 1997-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100462431-B1 |
| titleOfInvention | Novel mouse cxc chemokine receptor |
| abstract | A polypeptide comprising the whole amino acid sequence set forth in SEQ ID NO: 17 of the Sequence Listing or a portion thereof or a polypeptide comprising said polypeptide having receptor activity capable of binding to mouse PBSF / SDF-1; Polypeptides encoded by such DNA and having receptor activity capable of binding mouse PBSF / SDF-1; Cells expressing such polypeptides and human CD4 protein; And screening methods such as AIDS onset inhibitors and HIV-1 infection inhibitors using the cells described above. Thus, the present invention provides novel mouse CXC chemokine receptor genes useful in the study of AIDS treatment or aspects of action in HIV-1 infection, screening methods for HIV-1 infection inhibitors, and the like. |
| priorityDate | 1997-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 438.